Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Topoisomerase II inhibitor")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1001

  • Page / 41
Export

Selection :

  • and

Anucleate cell blue assay : a useful tool for identifying novel type II topoisomerase inhibitorsOYAMADA, Yoshihiro; ITO, Hideaki; FUJIMOTO-NAKAMURA, Mika et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 1, pp 348-350, issn 0066-4804, 3 p.Article

Thanatop : A novel 5-nitrofuran that is a highly active, cell-permeable inhibitor of topoisomerase IIPOLYCARPOU-SCHWARZ, Maria; MÜLLER, Kerstin; DENGER, Stefanie et al.Cancer research (Baltimore). 2007, Vol 67, Num 9, pp 4451-4458, issn 0008-5472, 8 p.Article

Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIβMARCHION, Douglas C; BICAKU, Elona; TURNER, Joel G et al.Clinical cancer research. 2005, Vol 11, Num 23, pp 8467-8475, issn 1078-0432, 9 p.Article

Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cellsMAMIDIPUDI, Vidya; TAO SHI; BRADY, Helen et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 4, pp 965-976, issn 0344-5704, 12 p.Article

A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cellsPATRA, Nabanita; DE, Umasankar; KANG, Jin-Ah et al.European journal of pharmacology. 2011, Vol 658, Num 2-3, pp 98-107, issn 0014-2999, 10 p.Article

Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-MycBIDWELL, Gene L; RANCHER, Drazen.Biochemical pharmacology. 2005, Vol 71, Num 3, pp 248-256, issn 0006-2952, 9 p.Article

NBTI 5463 Is a Novel Bacterial Type II Topoisomerase Inhibitor with Activity against Gram-Negative Bacteria and In Vivo EfficacyDOUGHERTY, Thomas J; NAYAR, Asha; NEWMAN, Joseph V et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 5, pp 2657-2664, issn 0066-4804, 8 p.Article

The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabineWALSBY, Elisabeth J; COLES, Steven J; KNAPPER, Steven et al.Haematologica (Roma). 2011, Vol 96, Num 3, pp 393-399, issn 0390-6078, 7 p.Article

Interaction between double helix DNA fragments and the new antitumor agent sabarubicin, Men10755MAZZINI, Stefania; SCAGLIONI, Leonardo; ANIMATI, Fabio et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 4, pp 1497-1506, issn 0968-0896, 10 p.Article

Targeted Cancer Therapy with a 2-Deoxyglucose―Based Adriamycin ComplexJIE CAO; SISI CUI; SIWEN LI et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 4, pp 1362-1373, issn 0008-5472, 12 p.Article

Peroxiredoxins are involved in metallothionein protection from doxorubicin cardiotoxicityLI JING; YINGLIANG WU; JING WU et al.European journal of pharmacology. 2011, Vol 659, Num 2-3, pp 224-232, issn 0014-2999, 9 p.Article

Type IIA topoisomerase inhibition by a new class of antibacterial agentsBAX, Benjamin D; CHAN, Pan F; JIANZHONG HUANG et al.Nature (London). 2010, Vol 466, Num 7309, pp 935-940, issn 0028-0836, 6 p.Article

Tumor Cells Upregulate Normoxic HIF-1α in Response to DoxorubicinYITING CAO; EBLE, Joseph M; DEWHIRST, Mark W et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 20, pp 6230-6242, issn 0008-5472, 13 p.Article

Cardioprotective roles of aged garlic extract, grape seed proanthocyanidin, and hazelnut on doxorubicin-induced cardiotoxicityDEMIRKAYA, Erkan; AVCI, Aslihan; KESIK, Vural et al.Canadian journal of physiology and pharmacology. 2009, Vol 87, Num 8, pp 633-640, issn 0008-4212, 8 p.Article

Human Multiple Myeloma Cells Are Sensitized to Topoisomerase II Inhibitors by CRM1 InhibitionTURNER, Joel G; MARCHION, Douglas C; DAWSON, Jana L et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 17, pp 6899-6905, issn 0008-5472, 7 p.Article

Aldo-Keto Reductase 1C2 Fails to Metabolize Doxorubicin and Daunorubicin in VitroTAKAHASHI, Ryan H; BAINS, Onkar S; PFEIFER, Tom A et al.Drug metabolism and disposition. 2008, Vol 36, Num 6, pp 991-994, issn 0090-9556, 4 p.Article

Exercise protects against doxorubicin-induced markers of autophagy signaling in skeletal muscleSMUDER, Ashley J; KAVAZIS, Andreas N; MIN, Kisuk et al.Journal of applied physiology (1985). 2011, Vol 111, Num 4, pp 1190-1198, issn 8750-7587, 9 p.Article

P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 Determine the Pharmacokinetics of EtoposideLAGAS, Jurjen S; LIN FAN; WAGENAAR, Els et al.Clinical cancer research (Print). 2010, Vol 16, Num 1, pp 130-140, issn 1078-0432, 11 p.Article

Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposomeQING CHEN; KROL, Ava; WRIGHT, Alex et al.International journal of hyperthermia. 2008, Vol 24, Num 6, pp 475-482, issn 0265-6736, 8 p.Article

Relationship of mRNA expressions of RanBP2 and topoisomerase II isoforms to cytotoxicity of amrubicin in human lung cancer cell linesHORIO, Yoshitsugu; OSADA, Hirotaka; SHIMIZU, Junichi et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 2, pp 237-243, issn 0344-5704, 7 p.Article

Antiproliferative, Antiinvasive, and Proapoptotic Activity of Folate Receptor α-Targeted Liposomal Doxorubicin in Nonfunctional Pituitary Adenoma CellsXIAOHAI LIU; SIHAI MA; BING XIN et al.Endocrinology (Philadelphia). 2013, Vol 154, Num 4, pp 1414-1423, issn 0013-7227, 10 p.Article

Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patientsLA-BECK, Ninh M; ZAMBONI, Beth A; GABIZON, Alberto et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 1, pp 43-50, issn 0344-5704, 8 p.Article

Post Embolization Syndrome in Doxorubicin Eluting Chemoembolization with DC BeadPOMONI, Maria; MALAGARI, Katerina; MARINIS, Athanasios et al.Hepato-gastroenterology. 2012, Vol 59, Num 115, pp 820-825, issn 0172-6390, 6 p.Article

The modulatory effect of lithium on doxorubicin-induced cardiotoxicity in ratRAHIMI BALAEI, Maryam; MOMENY, Majid; BABAEIKELISHOMI, Rohollah et al.European journal of pharmacology. 2010, Vol 641, Num 2-3, pp 193-198, issn 0014-2999, 6 p.Article

p73 participates in male germ cells apoptosis induced by etoposideCODELIA, Verónica A; CISTERNA, Matias; ALVAREZ, Alejandra R et al.Molecular human reproduction. 2010, Vol 16, Num 9-10, pp 734-742, issn 1360-9947, 9 p.Article

  • Page / 41